Insulet Corporation [PODD] stock is trading at $298.27, up 2.33%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PODD shares have gain 4.05% over the last week, with a monthly amount drifted -5.06%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on June 16, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $365. Previously, Goldman started tracking the stock with Buy rating on May 30, 2025, and set its price target to $380. On May 13, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $350 on the stock. Wolfe Research downgraded its rating to a Peer Perform. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $340 as its price target on March 06, 2025. Bernstein started tracking with a Outperform rating for this stock on November 06, 2024, and assigned it a price target of $300. In a note dated May 30, 2024, Redburn Atlantic initiated an Buy rating and provided a target price of $235 on this stock.
Insulet Corporation [PODD] stock has fluctuated between $173.00 and $329.33 over the past year. Currently, Wall Street analysts expect the stock to reach $322 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $298.27 at the most recent close of the market. An investor can expect a potential return of 7.96% based on the average PODD price forecast.
Analyzing the PODD fundamentals
Insulet Corporation [NASDAQ:PODD] reported sales of 2.20B for the trailing twelve months, which represents a growth of 28.82%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.18%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.35 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 293.36 points at the first support level, and at 288.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 301.71, and for the 2nd resistance point, it is at 305.15.
Ratios To Look Out For
For context, Insulet Corporation’s Current Ratio is 4.43. As well, the Quick Ratio is 3.59, while the Cash Ratio is 2.47. Considering the valuation of this stock, the price to sales ratio is 9.55, the price to book ratio is 15.77 and price to earnings (TTM) ratio is 53.68.
Transactions by insiders
Recent insider trading involved Singh Prem, SVP, Global Operations, that happened on Jun 13 ’25 when 2327.0 shares were sold. SVP, Chief HR Officer, Manea Dan completed a deal on Jun 13 ’25 to sell 1300.0 shares. Meanwhile, Officer Singh Prem bought 2327.0 shares on Jun 13 ’25.
